Related Articles| Prostate Cancer Breakthrough Receives FDA Clearance A new imaging device, ei-Nav/Artemis(TM), now officially cleared by the U.S. Food and Drug Administration (FDA), offers urologists breakthrough technology that will significantly help in the fight against prostate cancer. Artemis, designed by Eigen, a Nor |
| MOSAID Announces Share Buyback Program OTTAWA, ONTARIO-- - MOSAID Technologies Inc. today announced that it has amended the terms of its normal course issuer bid through the facilities of the Toronto Stock Exchange, commenced September 13, 2007, to increase the number of common shares to be pu |
|